Delivery Order SPE2DB20D1100-SPE2DB24FA5F6
Award Date
3/4/24
Potential Completion Date
3/25/24
Potential Value
$2.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,242.60 firm fixed price delivery order is for the supply of HEMANGEOL 4.28 MG/ML oral solution in 120 mL units, with a completion date of January 29, 2024. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML, a pharmaceutical product, with a potential value of $1,242.60 and a completion date of March 5, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor on this award. The contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,526.54 firm fixed-price delivery order is for the supply of HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML, a medication. The contract has an ultimate completion date of February 11, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,526.54 firm fixed-price delivery order is for the supply of the pharmaceutical product HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML. The contract has an ultimate completion date of April 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $1,263.27 and is for the delivery of HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML, a pharmaceutical product. The contract has an ultimate completion date of February 24, 2025 and is a firm fixed price delivery order. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The award, valued at $1,656.80, is for the supply of the pharmaceutical product Hemangeol 4.28 mg/ml oral solution, 120 ml. The contract has a firm fixed price pricing type and an ultimate completion date of August 16, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the supply of HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML, a pharmaceutical product, under contract ID SPE2DB20D1100|SPE2DB25FA3W4. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $3,368.72 and a period of performance through February 24, 2025. The contract was awarded on January 31,...
This is a $3,368.72 Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML, a pharmaceutical product, with a period of performance through March 10, 2025. This contract award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Hemangeol 4.28 mg/ml oral solution in 120 ml bottles. The contract has a ceiling value of $1,684.36 and a period of performance through April 30, 2025. The contract is not designated as a set-aside and was competitively awarded. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that provides a wide range of medical products and supplies...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide pharmaceutical products and medical supplies. The award, valued at $5,293.08, has a completion date of January 31, 2024. Amerisourcebergen Drug Corp, the prime contractor, is a for-profit organization that holds an indefinite delivery contract with DLA, valued up to $999,999,999.00 through December 31,...